These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36467807)

  • 21. Variant-specific discrepancy when quantitating BCR-ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay.
    Kjaer L; Skov V; Andersen MT; Aggerholm A; Clair P; Gniot M; Soeby K; Udby L; Dorff MH; Hasselbalch H; Pallisgaard N
    Eur J Haematol; 2019 Jul; 103(1):26-34. PubMed ID: 30985947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of rare atypical BCR-ABL1 transcript: A case report.
    Saha J; Gopinath V; Nair CK; Roshan D
    Indian J Pathol Microbiol; 2023; 66(3):624-626. PubMed ID: 37530356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions.
    May PC; Reid AG; Robinson ME; Khorashad JS; Milojkovic D; Claudiani S; ; Willis F; Apperley JF; Innes AJ
    BMC Med Genomics; 2023 Jul; 16(1):172. PubMed ID: 37496024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid Leukemia.
    Alikian M; Whale AS; Akiki S; Piechocki K; Torrado C; Myint T; Cowen S; Griffiths M; Reid AG; Apperley J; White H; Huggett JF; Foroni L
    Clin Chem; 2017 Feb; 63(2):525-531. PubMed ID: 27979961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.
    Lyu X; Yang J; Wang X; Hu J; Liu B; Zhao Y; Guo Z; Liu B; Fan R; Song Y
    Mol Cytogenet; 2016; 9():47. PubMed ID: 27350795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythroid variant evolving from chronic myeloid leukemia resistant to multiple tyrosine kinase inhibitors: a rare case report.
    Lee MH; Song A; Li JY
    Diagn Pathol; 2024 Jan; 19(1):21. PubMed ID: 38268039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-Step Multiplexed Droplet Digital Polymerase Chain Reaction for Quantification of p190 BCR-ABL1 Fusion Transcript in B-Lymphoblastic Leukemia.
    Martinez RJ; Kang Q; Nennig D; Bailey NG; Brown NA; Betz BL; Tewari M; Thyagarajan B; Bachanova V; Mroz P
    Arch Pathol Lab Med; 2022 Jan; 146(1):92-100. PubMed ID: 33769465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of rare BCR-ABL1 fusion transcripts in chronic myeloid leukemia patients.
    Arun AK; Senthamizhselvi A; Mani S; Vinodhini K; Janet NB; Lakshmi KM; Abraham A; George B; Srivastava A; Srivastava VM; Mathews V; Balasubramanian P
    Int J Lab Hematol; 2017 Jun; 39(3):235-242. PubMed ID: 28035733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular response to imatinib in chronic myeloid leukaemia with a variant e13a3 BCR-ABL1 fusion.
    McCarron SL; Langabeer SE; Bolger K; Haslam K; Crampe M; Kelly J; Morrell R
    Med Oncol; 2015 Feb; 32(2):452. PubMed ID: 25579165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
    Castagnetti F; Gugliotta G; Breccia M; Iurlo A; Levato L; Albano F; Vigneri P; Abruzzese E; Rossi G; Rupoli S; Cavazzini F; Martino B; Orlandi E; Pregno P; Annunziata M; Usala E; Tiribelli M; Sica S; Bonifacio M; Fava C; Gherlinzoni F; Bocchia M; Soverini S; Bochicchio MT; Cavo M; Giovanni M; Saglio G; Pane F; Baccarani M; Rosti G;
    Am J Hematol; 2017 Aug; 92(8):797-805. PubMed ID: 28466557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and outcomes of uncommon BCR-ABL1 fusion transcripts in patients with chronic myeloid leukaemia: data from a single centre.
    Qin YZ; Jiang Q; Jiang H; Lai YY; Shi HX; Chen WM; Yu L; Huang XJ
    Br J Haematol; 2018 Sep; 182(5):693-700. PubMed ID: 29974949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.
    Langabeer SE; McCarron SL; Kelly J; Krawczyk J; McPherson S; Perera K; Murphy PT
    Case Rep Hematol; 2012; 2012():458716. PubMed ID: 22937329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal Response in a Patient With CML Expressing
    Manzella L; Tirrò E; Vitale SR; Puma A; Consoli ML; Tambè L; Pennisi MS; DI Gregorio S; Romano C; Tomarchio C; DI Raimondo F; Stagno F
    In Vivo; 2020; 34(3):1481-1486. PubMed ID: 32354950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Myeloid Leukemia with an e6a2
    Crampe M; Haslam K; Groarke E; Kelleher E; O'Shea D; Conneally E; Langabeer SE
    Case Rep Hematol; 2017; 2017():9071702. PubMed ID: 29123930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence.
    Sugimoto T; Ijima K; Hisatomi H; Murayama T; Mizuno I; Hato A; Imoto S; Nishimura R; Koizumi T
    Am J Hematol; 2004 Oct; 77(2):164-6. PubMed ID: 15389825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.
    Ma W; Giles F; Zhang X; Wang X; Zhang Z; Lee TS; Yeh CH; Albitar M
    Int J Lab Hematol; 2011 Jun; 33(3):326-31. PubMed ID: 21266020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia.
    Jönsson S; Olsson B; Jacobsson S; Palmqvist L; Ricksten A; Ekeland-Sjöberg K; Wadenvik H
    Scand J Clin Lab Invest; 2011 Feb; 71(1):7-11. PubMed ID: 20863169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical presentation of patients with chronic myeloid leukemia in chronic phase-Case report.
    Ramdohr F; Fabarius A; Maier B; Bretschneider D; Jauch A; Monecke A; Metzeler KH; Janssen JWG; Schlenk RF; Kayser S
    Front Oncol; 2022; 12():960914. PubMed ID: 36106102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a novel multiplex RT-qPCR assay for the quantification of leukemia-associated BCR-ABL1 translocation.
    Kottwitz D; El Hadi H; El Amrani M; Cabezas S; Dehbi H; Nadifi S; Quessar A; Colomer D; Moumen A; Sefrioui EL
    Int J Hematol; 2015 Sep; 102(3):335-41. PubMed ID: 26243622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
    Schäfer V; White HE; Gerrard G; Möbius S; Saussele S; Franke GN; Mahon FX; Talmaci R; Colomer D; Soverini S; Machova Polakova K; Cross NCP; Hochhaus A; Ernst T
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):3081-3089. PubMed ID: 33677711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.